A Randomised, Open-Label, Active-Controlled, Parallel Group, Single-Centre, 4-Week Study to Evaluate the Safety of High Dose Budesonide after Multiple Dosing with Investigational HFA Metered Dose Inhaler and Conventional CFC Metered Dose Inhaler (Pulmicort) in Healthy Subjects.

Study identifier:D5252C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomised, Open-Label, Active-Controlled, Parallel Group, Single-Centre, 4-Week Study to Evaluate the Safety of High Dose Budesonide after Multiple Dosing with Investigational HFA Metered Dose Inhaler and Conventional CFC Metered Dose Inhaler (Pulmicort) in Healthy Subjects.

Medical condition

asthma

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Feb 2004
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria